Brief: Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
06/12/2024 13:06
Dec 6 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS ANNOUNCES THAT DEVELOPMENT PARTNER
TORII
PHARMACEUTICAL FILES NEW DRUG APPLICATION OF TO-208 THE
TREATMENT OF MOLLUSCUM CONTAGIOSUM IN JAPAN
Source text: ID:nGNXFN1fp
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data